HALOZYME THERAPEUTICS, INC. (HALO)

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.

Address

12390 EL CAMINO REAL
SAN DIEGO, CA 92130

Founded

1998

Number of Employees

373

Website

http://www.halozyme.com

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s )		 - - - - - $199,975 $224,982 $125,000 $90,213 $150,015 - $158,037
Average Price - - - - - $18.03 $27.25 $43.08 $43.09 $36.02 - $27.72
# Shares Purchased - - - - - 11,093,847 8,255,022 2,901,477 2,093,584 4,165,258 - 5,701,838
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date - - - - - 244.0% 127.5% 43.9% 43.9% 72.1% - 123.7%
S&P 500 Return to Date - - - - - 93.1% 74.8% 31.7% 37.3% 31.3% - 53.6%
Excess Total Return - - - - - 150.8% 52.7% 12.3% 6.6% 40.8% - 70.0%
Quartile Rank
Percentile Rank - - - - - 91% 80% 75% 76% 92% - 88%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed
GENMAB A/S
ALNYLAM PHARMACEUTICALS, INC.
CYTOKINETICS INC
LABARRE MICHAEL J.

HALOZYME THERAPEUTICS, INC.